Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank43
3Y CAGR-0.7%
5Y CAGR+30.6%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-0.7%/yr
vs +271.4%/yr prior
5Y CAGR
+30.6%/yr
Recent deceleration
Acceleration
-272.1pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.03 | +41.0% |
| 2024 | 0.02 | -57.7% |
| 2023 | 0.05 | +63.7% |
| 2022 | 0.03 | +244.8% |
| 2021 | 0.01 | +12.8% |
| 2020 | 0.01 | -83.3% |
| 2019 | 0.04 | +29192.4% |
| 2018 | 0.00 | -64.0% |
| 2017 | 0.00 | -93.4% |
| 2016 | 0.01 | - |